Multimodal Exercise Programs for Fall Prevention: A Randomized Controlled Trial

December 1, 2021 updated by: Hugo Filipe Zurzica Rosado, University of Évora

Multimodal Exercise Programs for Fall Prevention - Psychomotor Versus Psychomotor Combined With Whole-Body Vibration: A Randomized Controlled Trial

The aim of present study is to analyze and compare the effect of two exercise programs - psychomotor exercise program vs exercise combined program (psychomotor + whole body vibration) - on risk factors for falls of community-dwelling older adults who are fallers or are "at high risk of falling".

This experimental study is a randomized controlled trial. The program will run for 24 weeks (3 sessions / week of 75 minutes), followed by 12 weeks of follow-up without intervention. Participants of the groups will be assessed 1) at baseline, 2) at 12 weeks, 3) at 24 weeks, and 4) after the follow-up. Participants will be randomly allocated to three groups: experimental group 1 (psychomotor program); experimental group 2 (combined program) and control group.

Study Overview

Detailed Description

Aging is associated with a decline in executive functions, negatively influencing the motor, social and emotional capacities of older adults. (1) These losses will contribute to increase the risk of falling, so much that most falls occur during the performance of a dual-task (DT) (2).

The lack of balance, strength and poor body composition are seen as causes of falls, and should therefore be considered in the prevention programs of these events in older adults. (3-5) A psychomotor exercise program uses the body and movement as mediators, relying on the prevention of cognitive, sensory, perceptive, emotional and affective deterioration, exploring the neuroplasticity. (6,7) Therefore, this sensorimotor and neurocognitive program may prevent falls, but it is important to analyze its real impact in reducing either falls or the risk factors for falls in the older adults. No studies focusing on this subject were found.

The intervention through the whole body vibration (WBV) is referred in the literature as promoting the improvement of balance, mobility and agility, and preventing falls in the older adults.(8,9) WBV will have long-term therapeutic effects promoting the increase of muscle strength and increased bone mineral density. (10) Being two intervention methods with potential good results on falls prevention, it is not known whether there will be additional benefits in an intervention that combines both methods.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Évora, Portugal
        • Universidade de Évora

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male or female participants aged ≥65 years;
  • Community-dwelling older adults;
  • Older adults who have fallen in the last 6 months or who are at high risk of falling (scoring ≤25 points on Fullerton Advanced Balance Scale);
  • Participation agreement;

Exclusion Criteria:

  • Presence of severe cognitive decline (patients with a Mini-Mental State Examination ≤9);
  • Fracture in one or both lower limbs for less than 4 months;
  • Diagnosed of health conditions compromising the program participation, such as: severe osteoporosis (T ≤ 2.5, with the occurrence of one or more associated osteoporotic fractures); hip or knee prostheses; incapacitating cardiovascular conditions; epilepsy; cancer or metastases;
  • Do not wish to participate in the study;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Psychomotor exercise program
The experimental group 1 (EG1) intervention comprises a psychomotor program. The program integrates 3 sessions / week of 75 minutes on alternated days. The psychomotor intervention includes exercises promoting simultaneous motor and cognitive stimulation (interval training).

Each session includes: beginning ritual (5 min), warm-up (15 min), main section comprising the multimodal exercises (40 min), cool-down (10 min), and finishing ritual (5 min).

At the initial stage, the activation of different muscle groups will be performed, providing an elevation of the neurophysiological parameters. The main section (multimodal exercises) will be focused on the specific objectives through sensorimotor and neurocognitive activities. This section includes periods ranging 10-15 min of exercises mainly focused on motor stimulation- physical performance (cardiovascular, strength, balance, flexibility, agility and movement accuracy)- alternating with exercises mainly focused on cognitive stimulation- executive functions (planning ability, information processing speed, attention and dual-task performance).

At the cool-down the participants will normalize their physiological parameters. Finally, at the finishing ritual the participants share their sensations experienced.

Experimental: Combined exercise program
The experimental group 2 (EG2) intervention combines the psychomotor program with a WBV program. The program integrates 3 sessions / week of 75 minutes (including the 6 minutes of WBV) on alternated days.

The EG2 intervention combines the psychomotor exercise program with a WBV program. The program integrates 3 sessions / week of 75 minutes (including the 6 minutes of WBV) on alternated days.

The WBV will integrate 3 sessions / week of 6 minutes each, with programed increased exercise time, series, and frequencies throughout the intervention.

No Intervention: Control Group
Usual care. After the study, control group (CG) participants will be offered the opportunity to integrate a similar fall prevention program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline, between and within groups comparison, in Executive Function
Time Frame: 0,3,6,9 months
Outcome Measure - Trial Making Test (Part A and B) to assess information processing speed
0,3,6,9 months
Change from Baseline, between and within groups comparison, in Executive Function
Time Frame: 0,3,6,9 months
Outcome Measure - Deary-Liewald Reaction Timed task to assess single and dual-task performance
0,3,6,9 months
Change from Baseline, between and within groups comparison, in Executive Function
Time Frame: 0,3,6,9 months
Outcome Measure - Timed Up and Go (dual-task version) to assess dual-task performance
0,3,6,9 months
Change from Baseline, between and within groups comparison, in Executive Function
Time Frame: 0,3,6,9 months
Outcome Measure - The d2 Test of Attention to assess attention
0,3,6,9 months
Change from Baseline, between and within groups comparison, in Physical Performance
Time Frame: 0,3,6,9 months
Outcome Measure - Biodex (Peak Torque) to assess lower-body strength
0,3,6,9 months
Change from Baseline, between and within groups comparison, in Physical Performance
Time Frame: 0,3,6,9 months
Outcome Measure - Senior Fitness Test (30-s Chair Stand Test) to assess lower-body strength
0,3,6,9 months
Change from Baseline, between and within groups comparison, in Physical Performance
Time Frame: 0,3,6,9 months
Outcome Measure - Timed Up and Go (single and dual-task version) to assess agility
0,3,6,9 months
Change from Baseline, between and within groups comparison, in Physical Performance
Time Frame: 0,3,6,9 months
Outcome Measure - Static Posturography Platform to assess balance
0,3,6,9 months
Change from Baseline, between and within groups comparison, in Physical Performance
Time Frame: 0,3,6,9 months
Outcome Measure - Fullerton Advanced Balance Scale, ranging from 0 (worst) to 40 (best) points, to assess balance
0,3,6,9 months
Change from Baseline, between and within groups comparison, in Body Composition
Time Frame: 0,3,6,9 months
Outcome Measure - Dual-energy X-ray Absorptiometry to assess body fat mass (%) and body lean mass (%)
0,3,6,9 months
Change from Baseline, between and within groups comparison, in Body Composition
Time Frame: 0,3,6,9 months
Outcome Measure - Dual-energy X-ray Absorptiometry to assess bone mineral density
0,3,6,9 months
Fall occurrence in the previous 6 months at baseline and at post-intervention
Time Frame: 0,6 months
Comparasion of the number of falls between and within groups
0,6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Borg Rating of Perceived Exertion
Time Frame: 0-6 months
Exercise intensity
0-6 months
Mini-Mental State Examination
Time Frame: 0 months
Cognitive state
0 months
Composite Physical Function scale
Time Frame: 0 months
Physical independence
0 months
International Physical Activity Questionnaire
Time Frame: 0 months
Physical activity
0 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2018

Primary Completion (Actual)

October 30, 2018

Study Completion (Actual)

February 28, 2019

Study Registration Dates

First Submitted

February 7, 2018

First Submitted That Met QC Criteria

February 22, 2018

First Posted (Actual)

February 26, 2018

Study Record Updates

Last Update Posted (Actual)

December 16, 2021

Last Update Submitted That Met QC Criteria

December 1, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • UEvora

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fallers

Clinical Trials on Psychomotor exercise program

3
Subscribe